Your posts are always among the best because they provide a lot of scientific background and logical interpretations of such data. Thank you for your input.
Apparent Brilacidin has a lot of attractive features to offer in oh so many medical indications.
Excellent research and links, as always. Anti microbial peptides are indeed fascinating and their appeal is what got me interested in the company years back already now. It is fun to contemplate their use as anti viral agents.
What I object to is PRs that seem so preliminary. Maybe instead send out the B samples and have some tests done first, or get big Pharma interested enough to do the tests. Or say that AS will do tests in Italy.
Perhaps some smidgen of substance instead of style only.
Is that asking too much?
Where was IP and B for SARS and MERS? Now that the company has totally tanked- NOW they will put out anti viral stuff? Now?
What do you say to that? Timing is everything and now is the time that the stock is worthless
Market Data 
Markets 
